Amgen Inc. Increase (Decrease) of Restricted Investments
Amgen Inc. (AMGN) reported Increase (Decrease) of Restricted Investments of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseOfRestrictedInvestments · last filed 2017-02-14
- Amgen Inc. increase (decrease) of restricted investments for the quarter ending 2015-12-31 was $0.00.
- Amgen Inc. increase (decrease) of restricted investments for the quarter ending 2015-09-30 was $0.00.
- Amgen Inc. increase (decrease) of restricted investments for the quarter ending 2015-06-30 was $0.00.
- Amgen Inc. increase (decrease) of restricted investments for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- Amgen Inc. increase (decrease) of restricted investments for fiscal 2016 was $0.00.
- Amgen Inc. increase (decrease) of restricted investments for fiscal 2015 was $0.00.
- Amgen Inc. increase (decrease) of restricted investments for fiscal 2014 was -$533.00M.
- Amgen Inc. increase (decrease) of restricted investments for fiscal 2012 was $0.00.
| Period end | Increase (Decrease) of Restricted Investments 3 month | Increase (Decrease) of Restricted Investments 6 month | Increase (Decrease) of Restricted Investments 9 month | Increase (Decrease) of Restricted Investments 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-14 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $0.00 derived: sum of 2 quarters · filed 2017-02-14 | $0.00 derived: sum of 3 quarters · filed 2017-02-14 | $0.00 10-K · filed 2017-02-14 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $0.00 derived: sum of 2 quarters · filed 2015-11-02 | $0.00 10-Q · filed 2015-11-02 | $0.00 derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $0.00 10-Q · filed 2015-08-05 | $0.00 derived: sum of 3 quarters · filed 2017-02-14 | $0.00 derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $0.00 10-Q · filed 2015-04-27 | $0.00 derived: sum of 2 quarters · filed 2017-02-14 | $0.00 derived: sum of 3 quarters · filed 2017-02-14 | -$862.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $0.00 derived: sum of 2 quarters · filed 2017-02-14 | -$862.00M derived: sum of 3 quarters · filed 2017-02-14 | -$533.00M 10-K · filed 2017-02-14 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | -$862.00M derived: sum of 2 quarters · filed 2015-11-02 | -$533.00M 10-Q · filed 2015-11-02 | -$539.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-06-30 | -$862.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$533.00M 10-Q · filed 2015-08-05 | -$539.00M derived: sum of 3 quarters · filed 2016-10-31 | -$13.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-03-31 | $329.00M 10-Q · filed 2015-04-27 | $323.00M derived: sum of 2 quarters · filed 2016-10-31 | $849.00M derived: sum of 3 quarters · filed 2016-10-31 | $849.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2013-12-31 | -$6.00M derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $520.00M derived: sum of 2 quarters · filed 2016-10-31 | $520.00M derived: sum of 3 quarters · filed 2016-10-31 | $520.00M 8-K · filed 2016-10-31 |
| 2013-09-30 | $526.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $526.00M derived: sum of 2 quarters · filed 2014-10-29 | $526.00M 10-Q · filed 2014-10-29 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $0.00 10-Q · filed 2014-08-05 | ||
| 2013-03-31 | $0.00 10-Q · filed 2014-04-30 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-02-19 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |